Janus program clinical i

Ended Awarded Last action

Contract number
HHSF22317002
Awardee
Awarding agency
Obligated
$10,599,106

Award facts

Contract value 82% obligated
  • $10,599,106.20 Current, with exercised options
  • $12,904,049.00 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Competed under SAP · 2 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Arlington, VA 22209, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00008 · Executive order 14042, ensuring adequate covid safety protocols for federal contractors $0
Exercise an Option P00007 · Exercise option period 4 and include additional work $2,371,654
Other Administrative Action P00006 · Change COR to devine agbale $0
Other Administrative Action P00005 · Change COR $0
Exercise an Option P00004 · Exercise option year 2 and DE-scope-janus program clinical i $2,099,690
Exercise an Option P00003 · Exercise option year 2-janus program clinical i $1,956,486
Other Administrative Action P00002 · Change COR $0
Exercise an Option 1 $2,115,483
Original award $2,055,794

About this award

This is a firm fixed price BPA call contract awarded by the Department of Health and Human Services Food and Drug Administration to Deloitte Consulting LLP, doing business as Deloitte, with a potential value of $12,904,049.00. The contract is for the JANUS PROGRAM CLINICAL I requirement and does not have a set-aside designation. Deloitte is the prime contractor, and Goal Group LLC, doing business as TG Federal, is a subcontractor providing IT and consulting services in support of the contract. The contract was awarded on September 20, 2017, with a completion date of September 19, 2022. Deloitte is a management and technology consulting firm that has received numerous prime federal contract awards to support mission-critical initiatives across government agencies such as the Departments of Health and Human Services, Homeland Security, Defense, Treasury, and Veterans Affairs.

Quick answers

Who was awarded contract HHSF22317002?

HHSF22317002 was awarded to Deloitte Consulting LLP by Food and Drug Administration (Department of Health and Human Services) on September 20, 2017.

How much is contract HHSF22317002 worth?

The government has obligated $10,599,106 on HHSF22317002. Its potential value, with all options, is $12,904,049.

Is contract HHSF22317002 an order under another contract?

Yes. HHSF22317002 is a BPA call under HHSF223201610020B, a blanket purchase agreement.

Was contract HHSF22317002 competed?

The extent of competition for HHSF22317002 was competed under sap. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award